[PDF][PDF] Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection

…, I Cassaniti, E Percivalle, A Sarasini, F Bergami… - Med, 2021 - cell.com
Background Monitoring the adaptive immune responses during the natural course of severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection provides useful …

[HTML][HTML] Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

…, JC Sammartino, R Sun, S Vlachiotis, F Bergami… - Nature …, 2022 - nature.com
The recent emergence of the Omicron variant has raised concerns on vaccine efficacy and
the urgent need to study more efficient vaccination strategies. Here we observed that an …

[HTML][HTML] SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers

…, JC Sammartino, A Ferrari, F Bergami… - Nature …, 2021 - nature.com
Vaccine breakthrough SARS-CoV-2 infection has been monitored in 3720 healthcare workers
receiving 2 doses of BNT162b2. SARS-CoV-2 infection is detected in 33 subjects, with a …

[PDF][PDF] Immunity to SARS-CoV-2 up to 15 months after infection

…, Y Wang, S Vlachiotis, J Attevall, F Bergami… - IScience, 2022 - cell.com
Information concerning the longevity of immunity to SARS-CoV-2 following natural infection
may have considerable implications for durability of immunity induced by vaccines. Here, we …

[HTML][HTML] SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay

I Cassaniti, E Percivalle, F Bergami, A Piralla… - Clinical Microbiology …, 2021 - Elsevier
Objectives SARS-CoV-2 T-cell response characterization represents a crucial issue for defining
the role of immune protection against COVID-19. The aim of the study was to assess the …

Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects

…, A Ferrari, A Piralla, F Bergami… - Journal of Medical …, 2023 - Wiley Online Library
Monkeypox virus (MPXV) is a zoonotic disease endemic in the rainforest countries of
Central and West Africa. Understanding the immune response in zoonosis is fundamental to …

[HTML][HTML] Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational …

I Cassaniti, F Bergami, E Percivalle, E Gabanti… - Clinical Microbiology …, 2022 - Elsevier
Objectives To assess the humoral and cell-mediated response to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) elicited by the mRNA BNT162b2 vaccine in SARS-…

[HTML][HTML] Effect of a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine on humoral and cellular responses and serum anti-HLA antibodies in kidney transplant …

I Cassaniti, M Gregorini, F Bergami, F Arena… - Vaccines, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has severely
impacted on public health, mainly on immunosuppressed patients, including solid organ …

[HTML][HTML] Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?

…, C Terrosi, E Percivalle, EV Nepita, F Bergami… - International Journal of …, 2021 - Elsevier
Real-time reverse transcription PCR is currently the most sensitive method to detect severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Defining whether a patient could …

[HTML][HTML] Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: A longitudinal cohort …

A Lasagna, F Bergami, D Lilleri, E Percivalle… - ESMO open, 2022 - Elsevier
Background The role and the durability of the immunogenicity of the third dose of vaccine
against COVID-19 variants of concern in cancer patients have to be elucidated. Patients and …